Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,088,801
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Musunuri Shankar −$1.1M Chief Executive Officer sold 51% of stake
Date Insider Transaction Shares Price Value Owned after
2019-02-08 Lewis Michael Director Option exercise +403,845 4,014,415
2019-02-08 Lewis Michael Director Option exercise +1,244,444 5,258,859
2019-02-08 Lewis Michael Director Option exercise · Common Stock Warrant (Right to Buy) +403,845 0
2019-02-08 Lewis Michael Director Option exercise · Common Stock Warrant (Right to Buy) +1,244,444 0
2018-10-10 Lewis Michael Director Purchase +538,460 3,610,570
2018-10-10 Lewis Michael Director Purchase · Common Stock Warrant (Right to Buy) +403,845 403,845
2018-06-15 Lewis Michael Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-06-13 Lewis Michael Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-12-16 Lewis Michael Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2016-12-02 Lewis Michael Director Conversion +996,779 3,072,110
2016-12-02 Lewis Michael Director Conversion · Series A Convertible Preferred Stock −2,242.75 0
2016-09-29 Lewis Michael Director Grant or award +247,665 $2.25 $557K 2,075,331
2016-09-29 Lewis Michael Director Grant or award · Series A Convertible Preferred Stock −2,242.75 $1,000.00 $2.2M 0
2016-09-29 Lewis Michael Director Grant or award · Common Stock Warrant (Right to Buy) −1,244,444 0
2015-06-24 Lewis Michael Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-06-01 Lewis Michael Director Other disposition −89,441 1,827,666
2014-12-08 Lewis Michael Director Conversion +747,000 1,036,244
2014-12-08 Lewis Michael Director Conversion +492,618 1,528,862
2014-12-08 Lewis Michael Director Option exercise +11,502 $0.76 $9K 1,540,364
2014-12-08 Lewis Michael Director Sale −792 $11.00 $9K 1,539,572

Page 1 of 2 · 25 trades